ESCOZUL - CANCER

   
 
ESCOZUL proveedor LABIOFAM

ESCOZUL suppliers: Cuban State producers


Who they are.- Until 2010 it was formed by a group of prestigious scientific institutions that joined forces in a national project registered with the Cuban Department of Public Health under the name Proyecto Ramal ESCOZUL. Those institutions were:

1. Instituto Nacional de Oncología y Radiología. (INOR)
2. Instituto de Medicina Tropical ¨Pedro Kouri¨ (IPK)
3. Laboratorios Biológicos y Farmacéuticos. (LABIOFAM)
4. Facultad de Biología de la Universidad de la Habana.
5. Ministerio de Ciencia, Tecnología y Medio Ambiente. (CITMA)
6. Ministerio de Salud Pública (MINSAP).

This working group aimed to demonstrate the properties of the blue scorpion venom.

The protocol of patient care started in the mid 90s, when the medical summaries started to be received and the traditional medical records were elaborated and filed in the medical centers. For each patient there was a medical card where doctors regularly wrote down: type of traditional treatment followed by the patient, the patient's symptoms before starting the treatment with ESCOZUL, the length of time that the patient has been taking ESCOZUL and the patient's symptoms after taking ESCOZUL over a period of time. This allows doctors to monitor the patient's progress during treatment and gather evidence of effectiveness.

The concentration and dosage of the drug depended on both the type of cancer, and the progression of the disease. The medical group generally recomended a concentration of 0, 0023 mg / ml, for patients who were at stages 1 and 2. The dose given in these cases was between 20 and 100 ml per day. For patients in stages 3 and 4, or terminally ill patients, they recommended starting treatment with concentrations higher than 0.080 mg / ml, which could be increased throughout the treatment in order to reach the ideal concentration to fight disease . In these cases the dose ranged between 100 ml and 1 liter per day, could become even higher.


Present.

Due to high demand for the drug, LABIOFAM decided to use the blue scorpion venom in homeopathic form. They began formulating a homeopathic solution called VIDATOX of which has only been demonstrated analgesic properties as indicated in the prospectus.

After the registration of the homeopathic formula, this is sold in Cuba at a price of $ 230 per month of treatment and LABIOFAM no longer perform free consultations.

The drug concentrate, to which we all refer to as ESCOZUL, is no longer produced and handed over by the Cuban state institutions.

For patients who had spent years taking the concentrated formulation or ESCOZUL, it is maintained a closed program.

The use of homeopathy in cancer patients is of much resistance by the scientific community, largely because there is no scientifically proven property that could be attributed to homeopathy. Basically, homeopathy is to perform consecutive dilutionsof a substance so at the end there is no trace of the active ingredient in it. Homeopathy practitioners say that the water retains the properties of the active ingredient which was exposed. More information see here

As for the blue scorpion venom, all studies have demonstrated dose-dependency, ie. the higher the concentration of the poison and the dose of escozul, best results in the inhibition of malignant cell growth. The homeopathic version VIDATOX does not meet those goals. It is not called ESCOZUL, even though the laboratory has the patent on it, because it violates the original formulation of high doses of active principle.

For commercial reasons, the Cuban government prefers to sell the homeopathic version (VIDATOX). This does not mean that research on ESCOZUL have been discontinued, but it is not offered to the patient.